BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 35615152)

  • 1. Ultrasound evolution of parenchymal changes in the thyroid gland with autoimmune thyroiditis in children prior to the development of papillary thyroid carcinoma - a follow-up study.
    Januś D; Kujdowicz M; Wójcik M; Taczanowska-Niemczuk A; Kiszka-Wiłkojć A; Górecki W; Starzyk JB
    Front Endocrinol (Lausanne); 2023; 14():1172823. PubMed ID: 37124746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between thyroid autoantibodies and the risk of thyroid papillary carcinoma.
    Peng X; Zhu X; Cheng F; Zhou B; Zhu X; Zhu L
    Gland Surg; 2020 Aug; 9(4):950-955. PubMed ID: 32953604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilaterality as a Risk Factor for Recurrence in Papillary Thyroid Carcinoma.
    Kim H; Kwon H
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TPOAb and Thyroid Function Are Not Associated with Breast Cancer Outcome: Evidence from a Large-Scale Study Using Data from the Taxotere as Adjuvant Chemotherapy Trial (TACT, CRUK01/001).
    Muller I; Kilburn LS; Taylor PN; Barrett-Lee PJ; Bliss JM; Ellis P; Ludgate ME; Dayan CM
    Eur Thyroid J; 2017 Jul; 6(4):197-207. PubMed ID: 28868260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithyroid peroxidase antibody positivity is associated with lower incidence of metastasis in breast cancer.
    Kemal Y; Demirag G; Ekiz K; Yucel I
    Mol Clin Oncol; 2015 May; 3(3):629-632. PubMed ID: 26137279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for recurrence in patients with papillary thyroid carcinoma.
    Hakim Tawil JA; Rojas MF; Santivañez JJ; León L; González Devia D
    Ear Nose Throat J; 2023 Feb; ():1455613231158792. PubMed ID: 36802846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between thyroid peroxidase antibody and differentiated thyroid cancer: a systematic review and meta-analysis.
    Zhang H; Tian L; Wang X; Shi X
    Front Endocrinol (Lausanne); 2024; 15():1349041. PubMed ID: 38476675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical prediction models for cervical lymph node metastasis of papillary thyroid carcinoma.
    Luo S; Lai F; Liang R; Li B; He Y; Chen W; Zhang J; Li X; Xu T; Hou Y; Liu Y; Long J; Yang Z; Chen X
    Endocrine; 2024 May; 84(2):646-655. PubMed ID: 38175390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor.
    Marongiu A; Nuvoli S; De Vito A; Vargiu S; Spanu A; Madeddu G
    Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High TPOAb Levels (>1300 IU/mL) Indicate Multifocal PTC in Hashimoto's Thyroiditis Patients and Support Total Thyroidectomy.
    Dong S; Xia Q; Wu YJ
    Otolaryngol Head Neck Surg; 2015 Jul; 153(1):20-6. PubMed ID: 25917667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer.
    Ryu YJ; Yoon JH
    Surg Oncol; 2020 Sep; 34():67-73. PubMed ID: 32891356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of multifocal papillary thyroid cancer: A systematic review and meta-analysis.
    Cui L; Feng D; Zhu C; Li Q; Li W; Liu B
    Laryngoscope Investig Otolaryngol; 2022 Aug; 7(4):1224-1234. PubMed ID: 36000032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Thyroid Peroxidase Antibody Predicts Recurrence in Papillary Thyroid Carcinoma: A Consecutive Study With 5,770 Cases.
    Wang W; Wen L; Chen S; Su X; Mao Z; Ding Y; Chen Z; Chen Y; Ruan J; Yang J; Zhou J; Teng X; Fahey TJ; Li Z; Teng L
    Front Oncol; 2022; 12():881024. PubMed ID: 35615152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma.
    Song E; Oh HS; Jeon MJ; Chung KW; Hong SJ; Ryu JS; Baek JH; Lee JH; Kim WG; Kim WB; Shong YK; Kim TY
    Int J Cancer; 2019 Mar; 144(6):1414-1420. PubMed ID: 30357831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF
    Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ
    Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.